Fig. 4. Time course of the effect of intravenous (i.v., open circles) and
intracranial (i.c., filled circles) administration of eel angiotensin II (eANG
II). The dose of eANG II, 10-7 mol i.v. and
5x10-11 mol i.c., was chosen to obtain similar enhancement of
water intake. For comparison, the time course of the effect of intracranial
eel atrial natriuretic peptide (eANP, filled squares) is also shown. Water
intake was measured every 5 min, and expressed as mean ± S.E.M.
*P<0.05, **P<0.01, compared with
the value before administration at time zero (paired t-test).